Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CACI INTERNATIONAL INC /DE/CACI · Entity 3388 | EVP, Chief Operating Officer | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CACI INTERNATIONAL INC /DE/
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,595 |
Reported balance
After 2026-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 1,595 · Balance 1,595 F1: On October 1, 2026, Dr. Young was granted 1,595 performance restricted stock units. The PRSU's will vest on the third anniversary of the grant date based on the achievement of a three-year performance measure. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,595 |
Reported balance
After 2026-10-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-01 · Grant · Acquired 1,595 · Balance 1,595 F2: On October 1, 2026, Dr. Young was granted 1,595 restricted stock units. These restricted stock units will vest 1/3 per year for three years. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 1, 2026, Dr. Young was granted 1,595 performance restricted stock units. The PRSU's will vest on the third anniversary of the grant date based on the achievement of a three-year performance measure.
F2: On October 1, 2026, Dr. Young was granted 1,595 restricted stock units. These restricted stock units will vest 1/3 per year for three years.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 21:16 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | GrantRestricted Stock Units · Derivative | 1,595 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002142434-26-000004 · wk-form4_1791235008.xml · derivative · entry 2 Young David Anthony · CIK 0002142434 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,595 Underlying: CACI Common Stock · 1,595 shares Expires not disclosed F2 · derivative.exercise_price: On October 1, 2026, Dr. Young was granted 1,595 restricted stock units. These restricted stock units will vest 1/3 per year for three years. F2 · price: On October 1, 2026, Dr. Young was granted 1,595 restricted stock units. These restricted stock units will vest 1/3 per year for three years. F2 · derivative.exercise_date: On October 1, 2026, Dr. Young was granted 1,595 restricted stock units. These restricted stock units will vest 1/3 per year for three years. F2 · derivative.expiration_date: On October 1, 2026, Dr. Young was granted 1,595 restricted stock units. These restricted stock units will vest 1/3 per year for three years. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 21:16 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | GrantPerformance Restricted Stock Units · Derivative | 1,595 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002142434-26-000004 · wk-form4_1791235008.xml · derivative · entry 1 Young David Anthony · CIK 0002142434 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,595 Underlying: CACI Common Stock · 1,595 shares Expires not disclosed F1 · derivative.exercise_price: On October 1, 2026, Dr. Young was granted 1,595 performance restricted stock units. The PRSU's will vest on the third anniversary of the grant date based on the achievement of a three-year performance measure. F1 · price: On October 1, 2026, Dr. Young was granted 1,595 performance restricted stock units. The PRSU's will vest on the third anniversary of the grant date based on the achievement of a three-year performance measure. F1 · derivative.exercise_date: On October 1, 2026, Dr. Young was granted 1,595 performance restricted stock units. The PRSU's will vest on the third anniversary of the grant date based on the achievement of a three-year performance measure. F1 · derivative.expiration_date: On October 1, 2026, Dr. Young was granted 1,595 performance restricted stock units. The PRSU's will vest on the third anniversary of the grant date based on the achievement of a three-year performance measure. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 20:00 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | GrantRestricted Stock Units · Derivative | 4,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002142434-26-000002 · wk-form4_1782417633.xml · derivative · entry 1 Young David Anthony · CIK 0002142434 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,448 Underlying: CACI Common Stock · 4,448 shares Expires not disclosed F1 · derivative.exercise_price: On June 22, 2026, Mr. Young was granted 4,448 restricted stock units which vest ratably on June 22, 2027, June 22, 2028 and June 22, 2029. F1 · price: On June 22, 2026, Mr. Young was granted 4,448 restricted stock units which vest ratably on June 22, 2027, June 22, 2028 and June 22, 2029. F1 · derivative.exercise_date: On June 22, 2026, Mr. Young was granted 4,448 restricted stock units which vest ratably on June 22, 2027, June 22, 2028 and June 22, 2029. F1 · derivative.expiration_date: On June 22, 2026, Mr. Young was granted 4,448 restricted stock units which vest ratably on June 22, 2027, June 22, 2028 and June 22, 2029. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.